These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30748045)

  • 21. Re: Cost of neuromodulation therapies for overactive bladder: percutaneous tibial nerve stimulation versus sacral nerve stimulation: M. Martinson, S. MacDiarmid and E. Black J Urol 2013; 189: 210-216.
    Barnett G; Ockrim J
    J Urol; 2013 Oct; 190(4):1444-5. PubMed ID: 23886880
    [No Abstract]   [Full Text] [Related]  

  • 22. Are patents for methods of medical treatment contrary to the ordre public and morality or "generally inconvenient"?
    Mitnovetski O; Nicol D
    J Med Ethics; 2004 Oct; 30(5):470-5; discussion 475-7. PubMed ID: 15467080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Research and patents in the biomedical field].
    Schena FP
    G Ital Nefrol; 2002; 19(1):2-3. PubMed ID: 12165938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FDA Perspectives on the Regulation of Neuromodulation Devices.
    Marjenin T; Scott P; Bajaj A; Bansal T; Berne B; Bowsher K; Costello A; Doucet J; Franca E; Ghosh C; Govindarajan A; Gutowski S; Gwinn K; Hinckley S; Keegan E; Lee H; Mathews B; Misra S; Patel S; Tang X; Heetderks W; Hoffmann M; Pena C
    Neuromodulation; 2020 Jan; 23(1):3-9. PubMed ID: 31965667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroprotection trek--the next generation: neuromodulation I. Techniques--deep brain stimulation, vagus nerve stimulation, and transcranial magnetic stimulation.
    Andrews RJ
    Ann N Y Acad Sci; 2003 May; 993():1-13; discussion 48-53. PubMed ID: 12853290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neuromodulation in the management of neurogenic lower urinary tract dysfunction].
    Keppene V; Mozer P; Chartier-Kastler E; Ruffion A
    Prog Urol; 2007 May; 17(3):609-15. PubMed ID: 17622098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuromodulation in multiple sclerosis.
    Abboud H; Hill E; Siddiqui J; Serra A; Walter B
    Mult Scler; 2017 Nov; 23(13):1663-1676. PubMed ID: 29115915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patent protection for microbial technologies.
    Sherkow JS
    FEMS Microbiol Lett; 2017 Nov; 364(20):. PubMed ID: 29029027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Review of Spinal and Peripheral Neuromodulation and Neuroinflammation: Lessons Learned Thus Far and Future Prospects of Biotype Development.
    Chakravarthy KV; Xing F; Bruno K; Kent AR; Raza A; Hurlemann R; Kinfe TM
    Neuromodulation; 2019 Apr; 22(3):235-243. PubMed ID: 30311715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chronic pelvic pain syndrome: neurostimulation, neuromodulation and acupuncture].
    Walter M; Sammer U; Kessler TM
    Urologe A; 2012 Dec; 51(12):1683-91. PubMed ID: 23224254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuromodulation for chronic pain.
    Knotkova H; Hamani C; Sivanesan E; Le Beuffe MFE; Moon JY; Cohen SP; Huntoon MA
    Lancet; 2021 May; 397(10289):2111-2124. PubMed ID: 34062145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and quality of life after transcutaneous posterior tibial neuromodulation for faecal incontinence.
    Jiménez-Toscano M; Vega D; Fernandez-Cebrián JM; Valle Martín B; Jiménez-Almonacid P; Rueda Orgaz JA
    Colorectal Dis; 2015 Aug; 17(8):718-23. PubMed ID: 25704357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First-to-invent versus first-to-file: impact of the AIA.
    Rachinsky T; Sullivan C; Ghosh S; Resnick DS; Burton C; Armstrong M; Hanish JP; Sklan A
    Pharm Pat Anal; 2014 Jul; 3(4):353-9. PubMed ID: 25291309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noninvasive and invasive neuromodulation for the treatment of tinnitus: an overview.
    Vanneste S; De Ridder D
    Neuromodulation; 2012 Jul; 15(4):350-60. PubMed ID: 22494273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nutrigenomics patents and commercialization: old wine in a new bottle?
    Caulfield T
    OMICS; 2009 Feb; 13(1):63-7. PubMed ID: 19290812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hippocratic obligation to shareholder profit? Medical treatment patents and the Australian High Court in Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd [2013] HCA 50.
    Vines T
    J Law Med; 2014 Jun; 21(4):797-809. PubMed ID: 25087362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second medical use in Turkey.
    Baklaci E; Altınay M
    Pharm Pat Anal; 2016 Jul; 5(4):199-201. PubMed ID: 27334394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Must an inventor "possess" an invention to patent it?
    Woessner WD; Chadwick RA
    Cold Spring Harb Perspect Med; 2014 Sep; 4(11):a020867. PubMed ID: 25237144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Needleless Transcutaneous Neuromodulation Accelerates Postoperative Recovery Mediated via Autonomic and Immuno-Cytokine Mechanisms in Patients With Cholecystolithiasis.
    Zhang B; Zhu K; Hu P; Xu F; Zhu L; Chen JDZ
    Neuromodulation; 2019 Jul; 22(5):546-554. PubMed ID: 30277014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Patents and scientific research: an ethical-legal approach].
    Darío Bergel S
    Rev Derecho Genoma Hum; 2014; (41):39-62. PubMed ID: 25845205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.